First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301).
- DOI
- 10.1161/circep.122.010915
- Published
- 2022 Dec
- Container
- Circulation. Arrhythmia and electrophysiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1161/circep.122.010915,
title = {First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301).},
author = {Stambler BS and Plat F and Sager PT and Shardonofsky S and Wight D and Potvin D and Pandey AS and Ip JE and Coutu B and Mondésert B and Sterns LD and Bennett M and Anderson JL and Damle R and Haberman R and Camm AJ},
year = {2022},
journal = {Circulation. Arrhythmia and electrophysiology},
doi = {10.1161/circep.122.010915},
url = {https://doi.org/10.1161/circep.122.010915}
}RIS
TY - JOUR TI - First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301). AU - Stambler BS AU - Plat F AU - Sager PT AU - Shardonofsky S AU - Wight D AU - Potvin D AU - Pandey AS AU - Ip JE AU - Coutu B AU - Mondésert B AU - Sterns LD AU - Bennett M AU - Anderson JL AU - Damle R AU - Haberman R AU - Camm AJ PY - 2022 JO - Circulation. Arrhythmia and electrophysiology DO - 10.1161/circep.122.010915 UR - https://doi.org/10.1161/circep.122.010915 ER -
APA
BS, S., F, P., PT, S., S, S., D, W., D, P., AS, P., JE, I., B, C., B, M., LD, S., M, B., JL, A., R, D., R, H., & AJ, C. (2022). First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301).. Circulation. Arrhythmia and electrophysiology. https://doi.org/10.1161/circep.122.010915
Source records
- pubmed · retrieved 2026-09-27T07:31:18.161Z